The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 30, 2014
Filed:
Apr. 17, 2009
Applicants:
Jill Caswell, Belfast, GB;
Shane Olwill, Belfast, GB;
James Johnston, Belfast, GB;
Richard Buick, Belfast, GB;
Thomas Jaquin, Belfast, GB;
Declan Doherty, Belfast, GB;
Christopher Scott, Belfast, GB;
Inventors:
Jill Caswell, Belfast, GB;
Shane Olwill, Belfast, GB;
James Johnston, Belfast, GB;
Richard Buick, Belfast, GB;
Thomas Jaquin, Belfast, GB;
Declan Doherty, Belfast, GB;
Christopher Scott, Belfast, GB;
Assignee:
Fusion Antibodies Limited, Belfast, GB;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/00 (2006.01); C12P 21/08 (2006.01); C07K 16/22 (2006.01); A61K 39/395 (2006.01); C07K 16/28 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/22 (2013.01); A61K 2039/505 (2013.01); C07K 2317/31 (2013.01); C07K 2317/74 (2013.01); C07K 2317/33 (2013.01); C07K 2317/73 (2013.01); A61K 39/39558 (2013.01); C07K 16/2863 (2013.01);
Abstract
Described are cross-specific antibody molecules with binding specificity for both AREG and HBEGF. The antibody molecules may be used in methods of treatment of cancer and diseases associated with angiogenesis.